| PHARMA MAR, S.A., SOCIEDAD UNIPERSONAL Patent applications |
| Patent application number | Title | Published |
|---|
| 20090170860 | Use of PARP-1 Inhibitors - A method for improving the cytotoxic effect of Ecteinascidin-743 (ET-743) or an analog thereof on a tumor cell population in a patient the method including administering to the patient, sequentially or simultaneously, a therapeutically effective combination of a composition including ET-743 and an amount of a composition including a PARP-1 inhibitor effective to increase the cytotoxic effect of ET-743 on the tumor cell population. Anti-tumor compositions containing a therapeutically effective amount of ET-743 and an amount of a PARP-1 inhibitor effective to increase the tumor cytotoxicity of the ET-743 are also presented. | 07-02-2009 |
| 20090117176 | Anticancer Treatments - A method of treating the human body for cancer comprises administering an effective therapeutic amount of a Pegylated Liposomal form of the anthracycline Doxorubicin (“PLD”), in combination with an effective therapeutic amount of ET-743 | 05-07-2009 |
| 20080242670 | Anti-Inflammatory Agents - We have found anti-inflammatory activity in the ecteinascidin compounds. Such compounds have been widely described, and may have the following general formula (I), wherein: R | 10-02-2008 |
